FuseSchool
What Are Vaccinations?
Vaccinations protect both humans and animals from a wide range of preventable and potentially serious illnesses. With vaccines, we take advantage of one of the most important aspects of the immune system: the ability to develop...
FuseSchool
What are Antibodies
If this is the first time you have heard about antibodies, you may not know how important they are. Antibodies are one of the warriors inside our body, helping us to fight off nasty, invading particles. They are a type of protein, and...
Science360
Science Behind The News: Influenza & Flu Vaccines
Every flu season, Americans battle coughs, fevers and body aches. The flu is a respiratory illness caused by a virus, a pathogen that causes disease in the human body. To understand how the flu is caught, spread and treated, Duke...
Professor Dave Explains
Types of Immune Cells Part 1: Immune Cell Function
Ok, we are ready to investigate the immune system! So where do we start? Rather than starting on the big objects, like the organs in the lymphatic system, the best way to dive in is to briefly discuss the different types of cells that...
Curated Video
Drugmakers Seek Emergency Authorization For New COVID Vaccine
Sanofi's and GSK's vaccine uses a more conventional protein-based vaccine technology.
Press Association
Volunteers receive booster as part of Moderna Omicron vaccine trial
St George's, University of London, vaccinate volunteers as they begin their Moderna Omicron vaccine trial. First volunteer seen is Polly Fox, 25 (with interview) and second is Persephone du Parcq, 37. Final interview is Dr Catherine...
Press Association
Scientists conduct research in attempt to predict severity of coronavirus illness
Scientists are carrying out research to try and predict who will become seriously ill from coronavirus by analysing the immune response of patients. The Defence Science and Technology Laboratory at Porton Down, near Salisbury, is working...
Bloomberg
Projections of 2,000 Daily Covid Deaths ‘Not Unrealistic’: Johns Hopkins
Oct.26 -- Johns Hopkins Bloomberg School of Public Health Vice Dean Joshua Sharfstein discusses increased hospitalization and death from the latest surge of the coronavirus and the latest findings in Covid vaccine studies. He speaks on...
Bloomberg
AstraZeneca Begins U.S. Final-Stage Covid-19 Vaccine Trial
Sep.01 -- AstraZeneca Plc has begun testing its coronavirus vaccine in a large-scale human trial that could include up to 30,000 adults. Bloomberg Intelligence’s Sam Fazeli has the details on “Bloomberg Surveillance.”
Bloomberg
Fauci Is Almost Certain Virus Will Return in Winter, Is Optimistic About a Vaccine
Apr.30 -- Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, says he's "almost certain" coronavirus will return in the winter, but he's optimistic researchers will develop a vaccine. He speaks...
Bloomberg
Coronavirus Treatment: Antibodies and the Race for a Vaccine
May.04 -- Takeda President of Global Business Rajeev Venkayya discusses efforts among companies and nations to develop a coronavirus vaccine and the importance of making the vaccine available to the entire world. He speaks on "Bloomberg...
Curated Video
HIV studies show vaccines might control viral levels
1. Wide of speakers
2. Wide of people attending the briefing and the speaker on the podium
3. SOUNDBITE: (English) Dr Efthyhia Vardas, University of the Witwatersrand, Perinatal HIV Research Unit (PHRU), in Soweto:
"The majority of the...
Bloomberg
Fauci Is 'Cautiously Optimistic' a Covid-19 Vaccine Will Be Found
Apr.28 -- Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, says he's hopeful a vaccine for Covid-19 will be found by the winter. He speaks to David Rubenstein, host of "Peer-to-Peer...
Bloomberg
Unlikely Vaccine Efficacy Drops to Zero: Johns Hopkins
Johns Hopkins Center for Health Security Senior Scholar Gigi Gronvall discusses the use of existing vaccines to combat the omicron variant and the logistics of travel bans and testing. The Bloomberg School of Public Health is supported...
AFP News Agency
CLEAN : Mandelas lungs previously damaged spec
CLEAN : Mandelas lungs previously damaged spec
Bloomberg
Johnson & Johnson Begins Study of One-Dose Covid Shot
Sep.23 -- Johnson & Johnson has begun dosing up to 60,000 volunteers in a study of its Covid-19 vaccine, marking the first big U.S. trial of an inoculation that may work after just one shot. Bloomberg's Robert Langreth reports on...
Bloomberg
Mayo Clinic: Likely that Two-Dose Covid-19 Vaccine Will Be Needed
Jul.20 -- Mayo Clinic Vaccine Research Group Director Gregory Poland discusses the timeline for developing a Covid-19 vaccine and the supplies necessary to effectively distribute the immunizations on "Bloomberg Markets: European Close."
Bloomberg
Novavax to File Vaccine in U.K. and U.S. in Q2, CEO Says
Mar.12 -- Novavax Inc. Chief Executive Officer Stan Erck says the company's Covid-19 vaccine has been effective against variants. He speaks with Bloomberg's Alix Steel on "Bloomberg Markets."
Bloomberg
U.S. Registers Two Days of 100,000 Covid Cases: Johns Hopkins
Nov.06 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz discusses the surge in U.S. coronavirus cases, hospitalization and mortality in the current wave of illness, and provides an update on...
Bloomberg
How Dexamethasone Helps Lungs to Recover From Covid-19
Jun.18 -- Johns Hopkins University Professor of Nursing Jason Farley speaks on "Bloomberg Surveillance" about data showing that the generic steroid dexamethasone improves survival in severely ill Covid-19 patients. The Bloomberg School...
Bloomberg
Virus Case Level Is ‘Disconcerting’: Johns Hopkins’ Pekosz
Jul.17 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz discusses the surge in U.S. coronavirus cases, and how the virus is impacting younger individuals. He speaks on "Bloomberg Surveillance."...
Bloomberg
Developing a Vaccine for Coronavirus
Mar.30 -- Navid Malik, executive director of Life Sciences Division, discusses working with Stabilitech on a vaccine for coronavirus and how long it could be before one is on the market. He speaks on “Bloomberg Markets: European Open.”
Press Association
Impact of vaccine has potential to be very big, says Oxford academic
Interview on the Pfizer vaccine with Dr Peter Drobac, global health physician and social entrepreneur and Director of the Skoll Centre for Social Entrepreneurship at the University of Oxford’s Saïd Business School. Dr Drobac says the...
Curated Video
Zika Vaccine Trials Begin In Baltimore
RESTRICTION SUMMARY: AP CLIENTS ONLY; COURTESY: THE UNIVERSITY OF MARYLAND SCHOOL OF MEDICINESHOTLIST:AP TELEVISION - AP CLIENTS ONLYBaltimore, Maryland - 13 September 20161. Hallway at the Center for Vaccine Development at the...